Snapshot from Jul 19, 2026 at 14:14 UTC. For live data and tracking: View Live
Regulatory class action

Embecta securities class action lawsuit

Analysis based on 7 articles · First reported Jul 10, 2026 · Last updated Jul 16, 2026

Sentiment
-30
Attention
2
Articles
7
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

The lawsuit may negatively impact Embecta's stock price and investor confidence. The allegations of misleading guidance could lead to financial penalties and reputational damage.

medical devices

A class action lawsuit has been filed against Embecta Corp. (NASDAQ: EMBC) and certain of its officers by Bronstein, Gewirtz & Grossman, LLC, LLC, alleging violations of federal securities laws. The complaint claims that between November 25, 2025 and May 4, 2026, Embecta made materially false and misleading statements about its business and prospects, particularly regarding its pen needle sales and financial guidance. On May 5, 2026, Embecta reported a revenue decline of over 14% and lowered its fiscal year 2026 guidance, contrary to earlier positive statements. Investors who purchased Embecta securities during the class period have until August 17, 2026 to seek lead plaintiff status.

stock
Embecta is the defendant in the class action lawsuit, facing allegations of securities fraud. The company's stock may suffer due to investor concerns and potential legal costs.
Importance 100.0 Sentiment -40.0
priv
Bronstein, Gewirtz & Grossman, LLC is the law firm representing the class action plaintiffs. The firm is acting as legal counsel and stands to gain fees if the case is successful.
Importance 30.0 Sentiment 0.0
per
Peretz Bronstein is the founding partner of Bronstein, Gewirtz & Grossman, LLC and is involved in the case as a contact for investors.
Importance 10.0 Sentiment 0.0
per
Nathan Miller is a client relations manager at Bronstein, Gewirtz & Grossman, LLC, serving as a point of contact for investors.
Importance 5.0 Sentiment 0.0
Peretz Bronstein employer Nathan Miller Peretz Bronstein is a founding partner of Bronstein, Gewirtz & Grossman, LLC, where he employs and directs Nathan Miller
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.